“Challenges in clinical CEST MRI data processing”, with a focus on brain tumor characterization
Chemical Exchange Saturation Transfer (CEST) is a molecular imaging technique, which provides access to a whole spectrum of unique biomarkers. In recent years, CEST proved to offer an interesting way to detect and characterize different lesions with altered metabolic properties such as tumors. Endogenous CEST methods, such as Amide Proton Transfer (APT), are making their way in clinics due to their signal detectability on 3 Tesla clinical MRI scanners and due to the absence of contrast agent administration.
In this talk, Stefano Casagranda will discuss the challenges and different pre- / post- processing methods for obtaining CEST maps reliable and useful for multiparametric MRI.
Discussion points of the webinar:
by Stefano Casagranda, PhD
Senior Research & Innovation Engineer and Molecular Imaging Project Manager at Olea Medical
Stefano Casagranda is a trained Biomedical Engineer from the Università degli Studi di Pavia, Italy, with a specialty in Machine Learning applied to Healthcare. After completing his PhD in 2017 in Applied Mathematics to Biological Systems from INRIA (Institut National de Recherche en Informatique et en Automatique) in Sophia Antipolis, France, he joined the Research & Innovation team of Olea Medical®. Stefano Casagranda is now leading the development of CEST MRI products at Olea Medical®, where he can leverage his background on Machine Learning, Statistics and Mathematical Modeling. He is the author of several journal papers and conference abstracts.